C4BPA and Cognitive impairment: Moreover, the level of prion protein (PrP), a protein contributing to cognitive decline in PD patients, in plasma-derived EVs, negatively correlates with the cognitive performance of PD patients, suggesting that PrP in circulating EVs might be a potential biomarker for PD patients at risk of cognitive impairment [184].